10 Aug 2018 --- Global biotechnology company, Novozymes, has released its results for the first half. Earnings before interest and tax (EBIT) for the quarter came in at DKK957 million (US$147 million) with its household care sector showing particular weakness. The company still beat estimates with its second-quarter net profit and revenue, but shares have fallen after reporting earnings that missed analysts’ expectations.